Boston Children’s Hospital-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Boston Children's Hospital - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8012302
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:57
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Boston Children’s Hospital (Boston Children’s) is the pediatric medical center that provides a comprehensive range of health care services for children from birth through 21 years of age. Boston Children’s is the primary pediatric teaching affiliate of Harvard Medical School. The organization provides specialty services such as cardiovascular surgery, digestive care, blood diseases, fetal care and others. Its Advanced Fetal Care Center supports the needs of families and referring physicians at all steps of care for various congenital anomalies, from diagnosis and counseling through treatment and follow-up. It also collaborates with other institutes such as Harvard Stem Cell Institute, MIT Health Sciences & Technology, the Broad Institute, the Autism Consortium and Boston University. Boston Children’s is headquartered in Boston, Massachusetts, the US.

Boston Children’s Hospital – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Boston Children’s Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Boston Children’s Hospital, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Boston Children’s Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Boston Children’s Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Boston Children’s Hospital, Medical Devices Deals, 2011 to YTD 2017 10
Boston Children’s Hospital, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Boston Children’s Hospital, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
Amgen Enters into Research Agreement with Boston Children’s Hospital 13
Boston Children’s Hospital Enters into Agreement with GE Healthcare 14
Orchard Therapeutics Enters into Co-Development Agreement for Transformative Gene Therapies 15
Gruenenthal, Proteus and Boston Children’s Hospital Enter into Agreement 17
Grunenthal Enters into Agreement with Proteus and Boston Children’s Hospital 18
Fate Therapeutics Enters into Research Agreement with Boston Children’s Hospital 19
Boston Children’s Hospital Enters Into Co-Development Agreement With Abwiz Bio 20
Shire Enters Into Co-Development Agreement With Boston Children’s Hospital For Pediatric Therapies 21
Life Technologies Enters Into Co-Development Agreement With Boston Children’s Hospital 22
Children’s Hospital Boston Enters Into Research Agreement With Pfizer 23
Merger 24
Warren Hospital Merges With St. Luke’s Hospital 24
Licensing Agreements 25
Cambridge Epigenetix Enters into Licensing Agreement with Boston Children’s Hospital 25
Scholar Rock Enters into Licensing Agreement with Boston Children’s Hospital 26
Affinivax Enters into Licensing Agreement with Boston Children’s Hospital for MAPS Technology 27
Boston Children’s Hospital – Key Competitors 28
Boston Children’s Hospital – Key Employees 29
Boston Children’s Hospital – Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Joint Venture 35
Recent Developments 36
Government and Public Interest 36
Dec 06, 2017: Routing gene therapy directly into the brain 36
Nov 07, 2017: Boston Children’s Hospital Receives Grant to Support Malaria Research and Music Therapy Program Honoring Dr. Gary Loveman 38
Aug 14, 2017: Breakthrough Study By Pancreatic Cancer Action Network Grantee Evaluates Tumor Growth In Obese Vs. Lean Mice 39
Jul 06, 2017: NIH and Collaborators Identify the Genomic Cause for Carey-Fineman-Ziter Syndrome 40
May 12, 2017: Researchers find key molecule that could lead to new therapies for anemia 42
Mar 23, 2017: Effective one-shot vaccination of newborns moves closer to reality 44
Mar 20, 2017: New Research Identifies Novel Target for Controlling Immune Response to Implanted Materials 46
Sep 14, 2016: Discovery Offers Prospect of Shorter Treatment and Cure for Chronic Myelogenous Leukemia 47
Sep 08, 2016: New Vaccination Strategies Successfully Coach Immune System to Make Powerful HIV-Neutralizing Antibodies 48
Jul 06, 2016: A new angle for countering severe bacterial infections and sepsis 50
Jun 06, 2016: New approach could make bone marrow transplants safer 51
Jan 25, 2016: Researchers Show Novel Material Encapsulated Human Islet Cells Can Halt Type 1 Diabetes for Six Months 52
Jan 19, 2016: Immune 1-2-3 punch against parasites reveals potentially ancient cell death pathway 53
Product News 54
Sep 14, 2016: Antibiotic gel squirted into the ear could provide a one-dose cure for ear infections 54
Jan 11, 2016: Immune punch against parasites reveals potentially ancient cell death pathway 56
Appendix 57
Methodology 57
About GlobalData 57
Contact Us 57
Disclaimer 57

List of Tables
Boston Children's Hospital, Pharmaceuticals & Healthcare, Key Facts 2
Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Boston Children's Hospital, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Boston Children's Hospital, Deals By Therapy Area, 2011 to YTD 2017 9
Boston Children's Hospital, Medical Devices Deals, 2011 to YTD 2017 10
Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Amgen Enters into Research Agreement with Boston Children's Hospital 13
Boston Children's Hospital Enters into Agreement with GE Healthcare 14
Orchard Therapeutics Enters into Co-Development Agreement for Transformative Gene Therapies 15
Gruenenthal, Proteus and Boston Children's Hospital Enter into Agreement 17
Grunenthal Enters into Agreement with Proteus and Boston Children's Hospital 18
Fate Therapeutics Enters into Research Agreement with Boston Children's Hospital 19
Boston Children's Hospital Enters Into Co-Development Agreement With Abwiz Bio 20
Shire Enters Into Co-Development Agreement With Boston Children's Hospital For Pediatric Therapies 21
Life Technologies Enters Into Co-Development Agreement With Boston Children's Hospital 22
Children's Hospital Boston Enters Into Research Agreement With Pfizer 23
Warren Hospital Merges With St. Luke's Hospital 24
Cambridge Epigenetix Enters into Licensing Agreement with Boston Children’s Hospital 25
Scholar Rock Enters into Licensing Agreement with Boston Children's Hospital 26
Affinivax Enters into Licensing Agreement with Boston Children’s Hospital for MAPS Technology 27
Boston Children's Hospital, Key Competitors 28
Boston Children's Hospital, Key Employees 29
Boston Children's Hospital, Key Employees (cont..) 32
Boston Children's Hospital, Other Locations 34
Boston Children's Hospital, Subsidiaries 34
Boston Children's Hospital, Joint Venture 35

★海外企業調査レポート[Boston Children’s Hospital-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SURUGA bank Ltd:企業の戦略・SWOT・財務情報
    SURUGA bank Ltd - Strategy, SWOT and Corporate Finance Report Summary SURUGA bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • U-Haul International Inc:企業の戦略的SWOT分析
    U-Haul International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • GCL-Poly Energy Holdings Ltd (3800)-エネルギー分野:企業M&A・提携分析
    Summary GCL-Poly Energy Holdings Ltd. (GCL) is a provider of solar photovoltaic (PV) material and professional PV system solutions. The company produces and supplies high-quality solar grade and semiconductor grade polysilicon raw materials and silicon wafers to companies operating in the solar indu …
  • LOT Polish Airlines SA:企業の戦略・SWOT・財務情報
    LOT Polish Airlines SA - Strategy, SWOT and Corporate Finance Report Summary LOT Polish Airlines SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Lamb Weston Holdings, Inc. (LW):企業の財務・戦略的SWOT分析
    Lamb Weston Holdings, Inc. (LW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Jaiprakash Power Ventures Ltd (JPPOWER):電力:M&Aディール及び事業提携情報
    Summary Jaiprakash Power Ventures Ltd (Jaiprakash Power) is a power utility. It plans, develops, implements, and operates electric projects. The company produces electricity using hydro and coal sources. Jaiprakash Power also has development interests in the Hirong hydroelectric project and the Lowe …
  • Wolters Kluwer N.V. (WKL):企業の財務・戦略的SWOT分析
    Wolters Kluwer N.V. (WKL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Diagnostics For All Inc:企業の製品パイプライン分析
    Summary Diagnostics For All Inc (DFA) is a drug development company that develops and commercializes of new technology and practical diagnostic devices for diagnostic companies. The company uses patterned paper technology to create electrochemical clinical chemistry assays, immunoassays, assays, and …
  • China Huaneng Group:電力:M&Aディール及び事業提携情報
    Summary China Huaneng Group (CHNG) is a state-owned power generation company. It invests, develops, constructs, operates and manages power sources in China. The company develops coal-fired, hydro, wind, solar, nuclear and natural gas-fired power projects. CHNG also involved in the development, inves …
  • Apollo Education Group Inc:企業の戦略的SWOT分析
    Apollo Education Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Kerecis ehf:製薬・医療:M&Aディール及び事業提携情報
    Summary Kerecis ehf (Kerecis) is a medical device company that provides products that treats chronic wounds and damaged tissue. The company’s flagship product includes Kerecis Omega3 fish-skin acellular dermal matrix transplantation technology is intended for use in products to treat acute, chronic …
  • Tokmanni Group Oyj (TOKMAN):企業の財務・戦略的SWOT分析
    Tokmanni Group Oyj (TOKMAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Sumitomo Corp (8053):電力:M&Aディール及び事業提携情報
    Summary Sumitomo Corp (Sumitomo) is a multifaceted business enterprise. It operates various businesses such as metal products, transportation, construction systems, infrastructure, media, network & lifestyle retail, general products, real estate, financial services, logistics, mineral resources and …
  • Dana-Farber Cancer Institute Inc-医療機器分野:企業M&A・提携分析
    Summary Dana-Farber Cancer Institute Inc (Dana-Farber), formerly Sidney Farber Cancer Center is a cancer research center that offers treatment for different types of cancers. The center offers adults and children with various treatment options and also focuses on diagnosis, treatment, cure, and prev …
  • Orange SA:戦略・SWOT・企業財務分析
    Orange SA - Strategy, SWOT and Corporate Finance Report Summary Orange SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • U.S. Bancorp:企業の戦略・SWOT・財務情報
    U.S. Bancorp - Strategy, SWOT and Corporate Finance Report Summary U.S. Bancorp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Biogen Inc (BIIB):企業の財務・戦略的SWOT分析
    Biogen Inc (BIIB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Regeneron Pharmaceuticals Inc (REGN):製薬・医療:M&Aディール及び事業提携情報
    Summary Regeneron Pharmaceuticals Inc (Regeneron) is a biopharmaceutical company, which discovers, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. The company’s six US FDA-approved medicines and product candidates in development help patients wit …
  • GarrettCom, Inc.:企業の戦略的SWOT分析
    GarrettCom, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Toyo Tanso Co Ltd (5310):企業の財務・戦略的SWOT分析
    Toyo Tanso Co Ltd (5310) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆